Lifecore Biomedical
LFCR
LFCR
81 hedge funds and large institutions have $117M invested in Lifecore Biomedical in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 74 → 81 (+7)
0.4% more ownership
Funds ownership: 66.62% → 67.02% (+0.4%)
2% less capital invested
Capital invested by funds: $119M → $117M (-$2.41M)
Holders
81
Holding in Top 10
5
Calls
$425K
Puts
$109K
Top Buyers
| 1 | +$862K | |
| 2 | +$600K | |
| 3 | +$592K | |
| 4 |
BlackRock
New York
|
+$297K |
| 5 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$293K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$490K | |
| 3 | -$218K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$199K |
| 5 |
Man Group
London,
United Kingdom
|
-$199K |